FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Philippe Mangin

Research Profile

Disorders

Physiology

Concepts & Ideas

Procedures

Chemicals & Drugs

Geographic Areas

France

Anatomy

Genes & Molecular Sequences

Activities & Behaviors

Questionnaires

Co-author Network

Publications

TOP 3
Stéphane Larré; Nguyen Tran; Cheng Fan; Hikmat Hamadeh; Jaqueline Champigneulles; Rahmène Azzouzi; Olivier Cussenot; Philippe Mangin; Jean Luc Olivier
PGE2 and LTB4 tissue levels in benign and cancerous prostates.
Olivier Cussenot; Abdel-Rahmène Azzouzi; Gladys Bantsimba-Malanda; Cecile Gaffory; Philippe Mangin; Luc Cormier; Georges Fournier; Antoine Valeri; Lionel Jouffe; Morgan Roupret; Gaelle Fromont; Mathilde Sibony; Eva Comperat; Géraldine Cancel-Tassin
Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer.
Olivier Cussenot; Abdel-Rahmène Azzouzi; Nathalie Nicolaiew; Philippe Mangin; Luc Cormier; Georges Fournier; Antoine Valeri; Géraldine Cancel-Tassin
Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Philippe Mangin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Stéphane Larré; Nguyen Tran; Cheng Fan; Hikmat Hamadeh; Jaqueline Champigneulles; Rahmène Azzouzi; Olivier Cussenot; Philippe Mangin; Jean Luc Olivier
PGE2 and LTB4 tissue levels in benign and cancerous prostates.
Prostaglandins & other lipid mediators 2008;87(1-4):14-9.
2008: Olivier Cussenot; Abdel-Rahmène Azzouzi; Gladys Bantsimba-Malanda; Cecile Gaffory; Philippe Mangin; Luc Cormier; Georges Fournier; Antoine Valeri; Lionel Jouffe; Morgan Roupret; Gaelle Fromont; Mathilde Sibony; Eva Comperat; Géraldine Cancel-Tassin
Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(17):5635-9.
2007: Olivier Cussenot; Abdel-Rahmène Azzouzi; Nathalie Nicolaiew; Philippe Mangin; Luc Cormier; Georges Fournier; Antoine Valeri; Géraldine Cancel-Tassin
Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors.
European urology 2007;52(4):1082-7.
2007: Stéphane Larre; Abdel-Rahmène Azzouzi; Luc Cormier; Géraldine Cancel-Tassin; Isabelle Drelon; Françoise Baschet; Jean-Marie Villette; Olivier Cussenot; Philippe Mangin
[How is prostate cancer screening perceived by men 50 to 70 years of age? Analysis based on 1,774 screened individuals].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2007;17(5):939-42.
2007: Olivier Cussenot; Abdel-Rahmène Azzouzi; Nathalie Nicolaiew; Gaëlle Fromont; Philippe Mangin; Luc Cormier; Georges Fournier; Antoine Valeri; Stéphane Larre; Frédéric Thibault; Jean-Pierre Giordanella; Michel Pouchard; Yan Zheng; Freddie C Hamdy; Angela Cox; Géraldine Cancel-Tassin
Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3596-602.
2007: Stéphane Larré; Abdel-Rahmène Azzouzi; Géraldine Cancel-Tassin; Luc Cormier; Jean-Marie Villette; Philippe Hoffmann; Isabelle Drelon; Françoise Baschet; Philippe Mangin; Olivier Cussenot
[Impact of obesity on PSA in prostate cancer screening].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2007;17(4):815-8.
2007: Abdel-Rahmène Azzouzi; Dominique Stoppa-Lyonnet; Morgan Roupret; Stéphane Larre; Philippe Mangin; Olivier Cussenot
BRCA2 mutation screening is clinically relevant in breast and early prostate cancer families.
International journal of urology : official journal of the Japanese Urological Association 2007;14(5):445-6.
2007: Abdel-Rahmène Azzouzi; Stéphane Larre; Luc Cormier; Morgan Roupret; Antoine Valeri; Philippe Mangin; Philippe Berthon; Jean-Marie Villette; Jean Fiet; Olivier Cussenot
Relevance of the prostate-specific antigen (PSA) nanotest compared to the classical PSA test in the organized mass screening of prostate cancer.
BJU international 2007;99(4):762-4.
2004: Gaëlle Fromont; Laurent Chene; Alain Latil; Ivan Bieche; Michel Vidaud; Guy Vallancien; Philippe Mangin; Georges Fournier; Pierre Validire; Olivier Cussenot
Molecular profiling of benign prostatic hyperplasia using a large scale real-time reverse transcriptase-polymerase chain reaction approach.
The Journal of urology 2004;172(4 Pt 1):1382-5.
2004: Najla Amira; Géraldine Cancel-Tassin; Stéphane Bernardini; Béatrix Cochand-Priollet; Hugues Bittard; Philippe Mangin; Georges Fournier; Alain Latil; Olivier Cussenot
Expression in bladder transitional cell carcinoma by real-time quantitative reverse transcription polymerase chain reaction array of 65 genes at the tumor suppressor locus 9q34.1-2: identification of 5 candidates tumor suppressor genes.
International journal of cancer. Journal international du cancer 2004;111(4):539-42.
2004: Xavier Roumier; Rahmene Azzouzi; Antoine Valéri; Francis Guillemin; Georges Fournier; Olivier Cussenot; Philippe Mangin; Luc Cormier
Adherence to an annual PSA screening program over 3 years for brothers and sons of men with prostate cancer.
European urology 2004;45(3):280-5; author reply 285-6.
2003: Xavier Roumier; Alain Blum; Marian Devonec; Philippe Mangin; Luc Cormier; Jacques Hubert
[Evaluation of the accuracy of four-channel multidetector CT for investigation of the renal arterial blood supply].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2003;13(6):1311-5.
2003: S Mallick; Rahmene Azzouzi; Luc Cormier; D Peiffert; Philippe Mangin
Urinary morbidity after 125I brachytherapy of the prostate.
BJU international 2003;92(6):555-8.
2003: Géraldine Cancel-Tassin; Alain Latil; Francis Rousseau; Philippe Mangin; Emmanuel Bottius; Jean-Louis Escary; Philippe Berthon; Olivier Cussenot
Association study of polymorphisms in the human estrogen receptor alpha gene and prostate cancer risk.
European urology 2003;44(4):487-90.
2003: Abdel-Rahmène Azzouzi; Antoine Valeri; Luc Cormier; Georges Fournier; Philippe Mangin; Olivier Cussenot
Familial prostate cancer cases before and after radical prostatectomy do not show any aggressiveness compared with sporadic cases.
Urology 2003;61(6):1193-7.
2003: Antoine Valeri; Laurent Briollais; Rahmene Azzouzi; Georges Fournier; Philippe Mangin; Philippe Berthon; Olivier Cussenot; Florence Demenais
Segregation analysis of prostate cancer in France: evidence for autosomal dominant inheritance and residual brother-brother dependence.
Annals of human genetics 2003;67(Pt 2):125-37.
2002: Antoine Valeri; Luc Cormier; Marie-Pierre Moineau; Géraldine Cancel-Tassin; Rahmene Azzouzi; Laurent Doucet; Francoise Baschet; Isabelle Cussenot; Joel L'Her; Philippe Berthon; Philippe Mangin; Olivier Cussenot; Jean-Francois Morin; Georges Fournier
Targeted screening for prostate cancer in high risk families: early onset is a significant risk factor for disease in first degree relatives.
The Journal of urology 2002;168(2):483-7.
2002: Luc Cormier; Francis Guillemin; Antoine Valéri; Georges Fournier; Olivier Cussenot; Philippe Mangin; Mark S Litwin
Impact of prostate cancer screening on health-related quality of life in at-risk families.
Urology 2002;59(6):901-6.
2002: Luc Cormier; Antoine Valéri; Rahmene Azzouzi; Georges Fournier; Olivier Cussenot; Philippe Berthon; Francis Guillemin; Philippe Mangin
Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing.
The Prostate 2002;51(4):276-85.
2002: S Mallick; Rahmene Azzouzi; P Bey; Luc Cormier; J L Moreau; D Peiffert; Philippe Mangin
[Acute urinary complications after prostate iodine-125 brachytherapy: evaluation and risk factors].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2002;6(2):99-105.
2001: Géraldine Cancel-Tassin; Alain Latil; Antoine Valéri; E Guillaume; Philippe Mangin; Georges Fournier; Philippe Berthon; Olivier Cussenot
No evidence of linkage to HPC20 on chromosome 20q13 in hereditary prostate cancer.
International journal of cancer. Journal international du cancer 2001;93(3):455-6.
2001: Géraldine Cancel-Tassin; Alain Latil; Antoine Valéri; Philippe Mangin; Georges Fournier; Philippe Berthon; Olivier Cussenot
PCAP is the major known prostate cancer predisposing locus in families from south and west Europe.
European journal of human genetics : EJHG 2001;9(2):135-42.
2000: Antoine Valeri; Rahmene Azzouzi; E Drelon; André Delannoy; Philippe Mangin; Georges Fournier; Philippe Berthon; Olivier Cussenot
Early-onset hereditary prostate cancer is not associated with specific clinical and biological features.
The Prostate 2000;45(1):66-71.
2000: Antoine Valeri; Georges Fournier; V Morin; J F Morin; E Drelon; Philippe Mangin; Pierre Teillac; Philippe Berthon; Olivier Cussenot
Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives.
International journal of cancer. Journal international du cancer 2000;86(6):883-7.
1999: LS Correa-Cerro; Philippe Berthon; Jürgen Häussler; Sylvia Bochum; E Drelon; Philippe Mangin; Georges Fournier; Thomas Paiss; Olivier Cussenot; Walther Vogel
Vitamin D receptor polymorphisms as markers in prostate cancer.
Human genetics 1999;105(3):281-7.
1999: Antoine Valeri; E Drelon; Thomas Paiss; Walther Vogel; Robert De Petriconi; Richard Hautmann; Georges Fournier; Philippe Mangin; Philippe Berthon; Olivier Cussenot
[Genetic analysis of familial prostatic cancer: localization of a gene predisposing to prostatic cancer (PCaP) on chromosome 1q 42.2-43].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 1999;9(4):680-8.
1999: Antoine Valeri; E Drelon; Rahmene Azzouzi; André Delannoy; Pierre Teillac; Georges Fournier; Philippe Mangin; Philippe Berthon; Olivier Cussenot
[Epidemiology of familial prostatic cancer: 4-year assessment of French studies].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 1999;9(4):672-9.
1999: LS Correa-Cerro; Gudrun Wöhr; Jürgen Häussler; Philippe Berthon; E Drelon; Philippe Mangin; Georges Fournier; Olivier Cussenot; Peter H Kraus; Walter Just; Thomas Paiss; J M Cantú; Walther Vogel
(CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population.
European journal of human genetics : EJHG 1999;7(3):357-62.
1998: Philippe Berthon; Antoine Valeri; A Cohen-Akenine; E Drelon; Thomas Paiss; Gudrun Wöhr; Alain Latil; P Millasseau; I Mellah; N Cohen; Hélène Blanché; C Bellané-Chantelot; Florence Demenais; Pierre Teillac; Alain Le Duc; Robert De Petriconi; Richard Hautmann; I Chumakov; L Bachner; NJ Maitland; Rosette Lidereau; Walther Vogel; Georges Fournier; Philippe Mangin; Olivier Cussenot
Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43.
American journal of human genetics 1998;62(6):1416-24.
1998: Olivier Cussenot; Antoine Valeri; Philippe Berthon; Georges Fournier; Philippe Mangin
Hereditary prostate cancer and other genetic predispositions to prostate cancer.
Urologia internationalis 1998;60 Suppl 2():30-4; discussion 35.
1998: Philippe Mangin; Luc Cormier; Antoine Valéri
[Should we screen for prostate cancer?].
Annales d'urologie 1998;32(2):63-7.
1996: Antoine Valeri; Philippe Berthon; Georges Fournier; J C Buzzi; L Briollais; Paul Meria; H Blanche; C Bellanne-Chantelot; Pierre Teillac; F Demenais; Philippe Mangin; N Cohen; Alain Le Duc; Olivier Cussenot
[The PROGENE study, the French project of genetic analysis of familial prostatic cancer: recruitment and analysis].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 1996;6(2):226-35.